HIV/AIDS Therapy
Data on HIV/AIDS therapy discussed by researchers at University of Turin, Department of Infectious Diseases
Published in AIDS Weekly, April 30th, 2007
Current study results from the report, "Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus," have been published. According to recent research from Turin, Italy, "To evaluate the early anti-HIV activity of pegylated interferon (PEG-IFN) alfa-2a and ribavirin in HIV/hepatitis C virus (HCV) co-infected patients not receiving antiretroviral therapy. In 19 patients with baseline plasma HIV load (HIV-RNA) >1000 copies/mL treated with PEG-IFN alfa-2a and ribavirin, HIV-RNA and T-cell subsets were measured at baseline and 2, 4 and 12 weeks after initiation of anti-HCV therapy. We observed a significant HIV-RNA decrease (>1 log(10)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-04-30)
More Articles from AIDS Weekly
- HIV/AIDS
AIDS Drug Assistance Programs (ADAPs) Require National Solution - HIV/AIDS
Avexa Secures CCR5 Inhibitor HIV Program With TargetDrug - HIV/AIDS
Koronis Pharmaceuticals Receives Notice of Allowance on Patent for Novel Therapeutic KP-1461 in Development for Treatment of HIV - HIV/AIDS
Millenia Hope Inc receives a grant from the National Institutes of Health (USA) to develop new HIV therapeutics in consortium with the University of Pittsburgh and Rutgers University - HIV/AIDS
Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China - HIV/AIDS
What is the Estimated Value of the Brazilian Bioequivalent Generic Market Now & in 2012? - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
